The development of effector T cell subsets in murine Leishmania major infection - PubMed

Affiliations

• PMID: 8724833
• DOI: 10.1002/9780470514849.ch8

Review

The development of effector T cell subsets in murine Leishmania major infection

R M Locksley et al. Ciba Found Symp. 1995.

Abstract

Leishmania major infection has proven an exceptional model for CD4+ subset development in inbred mice. Most strains contain infection coincident with the appearance of T helper 1 (Th1) cells that produce gamma-interferon (IFN-gamma) required for macrophage activation. In contrast, mice on the BALB background are unable to control infection due to the development of Th2 cells that produce counter-regulatory cytokines, particularly interleukin 4 (IL-4), capable of abrogating the effects of IFN-gamma. Selective gene disruption studies in mice have illustrated critical components of the host response to L. major. Mice deficient in beta 2 microglobulin, which have no major histocompatibility complex (MHC) class I or CD8+ T cells, control infection as well as wild-type mice, whereas mice deficient in MHC class II (and CD4+ T cells) suffer fatal infection. Mice with disruption of the gene coding IFN-gamma are also incapable of containing infection, reflecting absolute requirements for this cytokine. A number of interventions have been demonstrated to abrogate Th2 cell development in BALB mice, enabling these mice to control infection. Each of these--IL-12, anti-IL-4, anti-IL-2, anti-CD4 and CTLA4-Ig--has in common the capacity to make IL-4 rate limiting at the time of CD4+ cell priming.

Similar articles

• Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.

  Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G. Mattner F, et al. Eur J Immunol. 1996 Jul;26(7):1553-9. doi: 10.1002/eji.1830260722. Eur J Immunol. 1996. PMID: 8766560

• The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.

  Aseffa A, Gumy A, Launois P, MacDonald HR, Louis JA, Tacchini-Cottier F. Aseffa A, et al. J Immunol. 2002 Sep 15;169(6):3232-41. doi: 10.4049/jimmunol.169.6.3232. J Immunol. 2002. PMID: 12218142

• Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

  Powrie F, Correa-Oliveira R, Mauze S, Coffman RL. Powrie F, et al. J Exp Med. 1994 Feb 1;179(2):589-600. doi: 10.1084/jem.179.2.589. J Exp Med. 1994. PMID: 7905019 Free PMC article.

• Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.

  Louis JA, Conceiçao-Silva F, Himmelrich H, Tacchini-Cottier F, Launois P. Louis JA, et al. Adv Exp Med Biol. 1998;452:53-60. doi: 10.1007/978-1-4615-5355-7_7. Adv Exp Med Biol. 1998. PMID: 9889959 Review.

• Cytokines in parasitic diseases: the example of cutaneous leishmaniasis.

  Launois P, Tacchini-Cottier F, Parra-Lopez C, Louis JA. Launois P, et al. Int Rev Immunol. 1998;17(1-4):157-80. doi: 10.3109/08830189809084491. Int Rev Immunol. 1998. PMID: 9914947 Review.

Cited by

• CD4+ T Cells: guardians of the phagosome.

  Tubo NJ, Jenkins MK. Tubo NJ, et al. Clin Microbiol Rev. 2014 Apr;27(2):200-13. doi: 10.1128/CMR.00097-13. Clin Microbiol Rev. 2014. PMID: 24696433 Free PMC article. Review.

• Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology.

  Gollob KJ, Antonelli LR, Faria DR, Keesen TS, Dutra WO. Gollob KJ, et al. Int Immunopharmacol. 2008 Oct;8(10):1338-43. doi: 10.1016/j.intimp.2008.03.016. Int Immunopharmacol. 2008. PMID: 18687296 Free PMC article. Review.

• Protective immunity and vaccination against cutaneous leishmaniasis.

  Okwor I, Mou Z, Liu D, Uzonna J. Okwor I, et al. Front Immunol. 2012 May 29;3:128. doi: 10.3389/fimmu.2012.00128. eCollection 2012. Front Immunol. 2012. PMID: 22661975 Free PMC article.

• Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses.

  Shi Z, Wakil AE, Rockey DC. Shi Z, et al. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10663-8. doi: 10.1073/pnas.94.20.10663. Proc Natl Acad Sci U S A. 1997. PMID: 9380692 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Research Materials

  • NCI CPTC Antibody Characterization Program